[go: up one dir, main page]

CL2012003685A1 - Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosing units in which each comprises at least 2 mg of drosperidone, without spoiling us; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a useful medication as a contraceptive. - Google Patents

Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosing units in which each comprises at least 2 mg of drosperidone, without spoiling us; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a useful medication as a contraceptive.

Info

Publication number
CL2012003685A1
CL2012003685A1 CL2012003685A CL2012003685A CL2012003685A1 CL 2012003685 A1 CL2012003685 A1 CL 2012003685A1 CL 2012003685 A CL2012003685 A CL 2012003685A CL 2012003685 A CL2012003685 A CL 2012003685A CL 2012003685 A1 CL2012003685 A1 CL 2012003685A1
Authority
CL
Chile
Prior art keywords
drosperidone
kit
units
pharmaceutical
contraceptive
Prior art date
Application number
CL2012003685A
Other languages
Spanish (es)
Inventor
Philippe Perrin
Jose Velada
Dominique Drouin
Original Assignee
Leon Farma Sa Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48802149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012003685(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leon Farma Sa Lab filed Critical Leon Farma Sa Lab
Publication of CL2012003685A1 publication Critical patent/CL2012003685A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Kit farmacéutico que comprende una o más unidades de envasado que comprenden 21 a 28 unidades de dosificación activas diarias en que cada una comprende por lo menos 2 mg de drosperidona, sin estrógenos; uso del kit y de una composición farmacéutica que comprende drosperidona para preparar un medicamento útil como anticonceptivo.Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosage units in which each comprises at least 2 mg of drosperidone, without estrogens; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a medicament useful as a contraceptive.

CL2012003685A 2010-06-29 2012-12-26 Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosing units in which each comprises at least 2 mg of drosperidone, without spoiling us; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a useful medication as a contraceptive. CL2012003685A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10305708 2010-06-29
US36839610P 2010-07-28 2010-07-28

Publications (1)

Publication Number Publication Date
CL2012003685A1 true CL2012003685A1 (en) 2013-07-05

Family

ID=48802149

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003685A CL2012003685A1 (en) 2010-06-29 2012-12-26 Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosing units in which each comprises at least 2 mg of drosperidone, without spoiling us; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a useful medication as a contraceptive.

Country Status (14)

Country Link
KR (1) KR102210982B1 (en)
BR (1) BR122019008317A2 (en)
CL (1) CL2012003685A1 (en)
CO (1) CO6640328A2 (en)
DK (1) DK2588114T3 (en)
EC (3) ECSP12012359A (en)
ES (1) ES2777886T3 (en)
GT (3) GT201200336BA (en)
HR (1) HRP20200155T1 (en)
HU (1) HUE047689T2 (en)
LT (2) LT2588114T (en)
MX (3) MX339952B (en)
PT (1) PT2588114T (en)
ZA (1) ZA201209743B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250129555A (en) 2024-02-22 2025-08-29 단국대학교 천안캠퍼스 산학협력단 Pharmaceutical composition for preventing or treating neurological diseases comprising drospirenone as an active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009138224A1 (en) * 2008-05-14 2009-11-19 Helm Ag Pharmaceutical composition comprising drospirenone

Also Published As

Publication number Publication date
ECSP15032911A (en) 2016-01-29
ZA201209743B (en) 2014-03-26
CO6640328A2 (en) 2013-03-22
ECSP12012359A (en) 2013-03-28
HUE047689T2 (en) 2020-05-28
BR122019008317A2 (en) 2020-09-29
LT2588114T (en) 2020-02-25
ES2777886T3 (en) 2020-08-06
MX2012014629A (en) 2013-05-06
MX339952B (en) 2016-06-20
DK2588114T3 (en) 2020-02-17
LTPA2021523I1 (en) 2021-11-10
PT2588114T (en) 2020-02-20
ECSP15032906A (en) 2016-01-29
GT201200336A (en) 2014-01-14
KR20190073598A (en) 2019-06-26
HRP20200155T1 (en) 2020-05-01
MX2019004393A (en) 2019-09-09
GT201200336AA (en) 2017-10-23
GT201200336BA (en) 2017-10-23
KR102210982B1 (en) 2021-02-02
MX364971B (en) 2019-05-16

Similar Documents

Publication Publication Date Title
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
GT200600445A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF THE ACTIVE PRINCIPLE.
MX392839B (en) SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT.
BR112015018087A8 (en) compound, pharmaceutical composition and use
EP4512394A3 (en) Dosage forms and use thereof
MX2015009772A (en) Spiro-lactam nmda receptor modulators and uses thereof.
ECSP10010224A (en) LUTEINIZING HORMONE LIQUID FORMULATIONS (LH).
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
AR084932A1 (en) OPHTHALMIC COMPOSITION INCLUDING AN ANDROGEN AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN EYE DISEASE RESULTING FROM AN ANDROGENIC DEFICIENCY
ECSP13012467A (en) USE OF BINDERS TO MANUFACTURE STORAGE FORMULATIONS TO STORAGE
CO6640305A2 (en) Preparation of granules without active ingredients and tablets comprising them
SV2017005602A (en) DROSPIRENONE-BASED CONTRACEPTIVE FOR FEMALE PATIENT AFFECTED WITH EXCESS WEIGHT
NI201000189A (en) SOLID MEDICINE FORMULATION WITH DELAYED RELEASE.
MX2014008284A (en) FORMULATION OF DELAYED RELEASE TO REDUCE THE FREQUENCY OF URINATING AND METHODS OF USE OF THIS.
MX2014008283A (en) FORMULATION OF PROLONGED RELEASE TO REDUCE THE FREQUENCY OF URINATING AND METHODS OF USE OF THIS.
GT201200304A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE HYDROMORPHONE AND NALOXONE
PH12012502082A1 (en) Combination of active loaded granules with additional actives
EA201400737A1 (en) DELIVERY SYSTEM ON THE BASIS OF A PELLET SET WITH IMMEDIATE release of an ACTIVE SUBSTANCE
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
EA201501164A1 (en) SOLID PHARMACEUTICAL MEDICINE FORM
PE20160850A1 (en) MULTIPARTICULATE SYSTEM FOR ADMINISTERING DRUGS
BRPI0700133A (en) pharmaceutical composition comprising tramadol and ketoprofen in combination
UY31010A1 (en) NEW REGIME OF DROSPIRENONA / 17B-ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR APPLICATION
ES2325291A1 (en) Use of a silybum marianum extract
CL2012003685A1 (en) Pharmaceutical kit comprising one or more packaging units comprising 21 to 28 daily active dosing units in which each comprises at least 2 mg of drosperidone, without spoiling us; use of the kit and a pharmaceutical composition comprising drosperidone to prepare a useful medication as a contraceptive.